Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Sees Large Increase in Short Interest

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) saw a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 100,700 shares, an increase of 15.5% from the November 15th total of 87,200 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

Newron Pharmaceuticals Price Performance

Shares of OTCMKTS:NWPHF remained flat at $9.36 during trading on Friday. Newron Pharmaceuticals has a 12 month low of $9.10 and a 12 month high of $12.00. The firm has a 50-day moving average price of $9.36 and a 200 day moving average price of $10.09.

Newron Pharmaceuticals Company Profile

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.